Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Treated With Immune-checkpoint Inhibitors”

224 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 224 results

Large-scale testing (Phase 3)Looking for participantsNCT06340568
What this trial is testing

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

Who this might be right for
Endometrial Cancer
BioNTech SE 480
Not applicableUnknownNCT06309862
What this trial is testing

Immune Checkpoint Inhibitor Therapy for Cancer and Risk of Myocarditis or Cardiomyopathy

Who this might be right for
Cardio-OncologyCardiomyopathy Due to Drug
Sunnybrook Health Sciences Centre 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361
What this trial is testing

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
University of Southern California 33
Testing effectiveness (Phase 2)Looking for participantsNCT07381075
What this trial is testing

A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
West China Hospital 90
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Testing effectiveness (Phase 2)WithdrawnNCT05660421
What this trial is testing

Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Douglas Johnson
Testing effectiveness (Phase 2)Looking for participantsNCT04592211
What this trial is testing

Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Who this might be right for
Gastric Cancer Stage IV
Yonsei University 71
Testing effectiveness (Phase 2)Looking for participantsNCT05758389
What this trial is testing

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

Who this might be right for
Head and Neck Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 29
Not applicableActive Not RecruitingNCT06117891
What this trial is testing

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

Who this might be right for
Unresectable Hepatocellular Carcinoma
Bayer 300
Not applicableNot Yet RecruitingNCT07206511
What this trial is testing

Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study

Who this might be right for
Unresectable Hepatocellular Carcinom
Shanghai Zhongshan Hospital 278
Large-scale testing (Phase 3)Looking for participantsNCT05727904
What this trial is testing

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Who this might be right for
Metastatic MelanomaUnresectable MelanomaMelanoma
Iovance Biotherapeutics, Inc. 670
Early research (Phase 1)Active Not RecruitingNCT04572451
What this trial is testing

Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma

Who this might be right for
MelanomaUnresectable Solid TumorsNeoplasms+7 more
Yana Najjar 50
Early research (Phase 1)Active Not RecruitingNCT06125197
What this trial is testing

Oncolytic Adenovirus TILT-123 With Pembrolizumab as Treatment for Refractory Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
TILT Biotherapeutics Ltd. 22
Early research (Phase 1)Looking for participantsNCT07231458
What this trial is testing

Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies

Who this might be right for
Advanced Solid Tumors
Abalos Therapeutics GmbH 27
Not applicableStudy completedNCT04253080
What this trial is testing

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Who this might be right for
Cutaneous Melanoma
Assistance Publique - Hôpitaux de Paris 127
Testing effectiveness (Phase 2)Looking for participantsNCT05010681
What this trial is testing

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma
Fudan University 25
Not applicableLooking for participantsNCT07086300
What this trial is testing

Electroacupuncture Combined With PD-1 Inhibitor for Elderly Patients With Advanced NSCLC

Who this might be right for
Elderly Patients (>65 Years)Non-Small Cell Lung CancerPD-1 Inhibitors+1 more
Kong Fanming 120
Not applicableLooking for participantsNCT07704918
What this trial is testing

Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

Who this might be right for
Melanoma
University of Colorado, Denver 40
Early research (Phase 1)UnknownNCT06356701
What this trial is testing

Tumor Nutritional Therapy in the First-line Treatment of Stage IV NSCLC

Who this might be right for
Long-Term Effects Secondary to Cancer Therapy
The First Affiliated Hospital of Dalian Medical University 120
Not applicableUnknownNCT04929353
What this trial is testing

SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

Who this might be right for
MelanomaLung Cancer
University Of Perugia 280
Next Page